Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript


Predictive Oncology Inc. (NASDAQ:POAI) Q1 2024 Earnings Call Transcript May 15, 2024 8:30 AM ET

Company Participants

Glenn Garmont – IR
Raymond Vennare – CEO and Chairman
Josh Blacher – CFO

Operator

Ladies and gentlemen, good morning, and thank you for standing by. Welcome to the Predictive Oncology Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be an opportunity to ask your questions. Please be advised that today’s conference is being recorded. And I would now like to hand the conference over to your speaker, Mr. Glenn Garmont, Investor Relations. Mr. Garmont, please go ahead.

Glenn Garmont

Welcome, and thank you, everyone, for dialing in to the Predictive Oncology First Quarter 2024 Financial Results Call. First, you’ll hear from our Chief Executive Officer and Chairman of the Board, Raymond Vennare. Then our Chief Financial Officer, Josh Blacher, will review our financials.

Certain matters discussed on this call contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements other than statements of historical facts included in the call regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, plans and objectives of management are forward-looking statements. The words anticipate, believe, estimate, expect, intend, may, plan, would, target and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may differ materially from that contemplated by the forward-looking statements as a result of a variety of factors, including, among other things, factors discussed under the heading Risk Factors in our filings with the SEC. Except as expressly required by law, the company disclaims any intent or obligation to update these forward-looking statements.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *